HIGHLIGHTS
- who: Daniel Sanchez-Tejerina and colleagues from the Barcelona Hospital Campus, Barcelona, Spain have published the research work: Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications, in the Journal: Cells 2023, 12, 1180. of /2023/
- what: In this review the authors aim to discuss the current status of fluid-based prognostic and predictive biomarkers in ALS with particular emphasis on those that are the most promising ones for clinical trial design and routine clinical practice. The Importance of the Study Sampling Focusing on biological fluid-based biomarkers, other relevant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.